Cost-effectiveness analysis of adjuvant docetaxel, doxorubicin, and cyclophosphamide (TAC) for node-positive breast cancer: modeling the downstream effects
Title:
Cost-effectiveness analysis of adjuvant docetaxel, doxorubicin, and cyclophosphamide (TAC) for node-positive breast cancer: modeling the downstream effects
Author:
Au, Heather-Jane Golmohammadi, Kamran Younis, Tallal Verma, Shailendra Chia, Stephen Fassbender, Konrad Jacobs, Philip